Tenderwize
Retour à la recherche

Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 05, 2027 · 188 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or guaranteed volume is provided. The commercial benefit is entirely dependent on the number of pres...

The open-house agreement automatically ceases if a formal discount contract for the same active substance is concluded...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive discount agreements for pharmaceutical products with active substances Formoterol and Aclidiniumbromid (ATC R03AL05)
  • Open-house model: no selection, all eligible companies can participate
Afficher le résumé complet

This is an open-house model (not a formal tender) by AOK Bayern for non-exclusive discount agreements on pharmaceutical products with active substances Formoterol and Aclidiniumbromid (ATC R03AL05). All interested pharmaceutical companies that meet the eligibility criteria can enter into identical, non-negotiable agreements. The earliest contract start is 01.05.2025, and all contracts end on 30.04.2027. Contracts can be concluded at any time until 05.03.2027. The notice is published for transparency but is not subject to procurement law. No estimated value is provided.

Risques

No estimated value or guaranteed volume is provided. The commercial benefit is entirely dependent on the number of pres...

The open-house agreement automatically ceases if a formal discount contract for the same active substance is concluded...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible

Administrative

  • Must submit a signed self-declaration of reliability
  • Must submit the signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Les exigences peuvent être incomplètes.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05

Non-exclusive discount agreements for pharmaceutical products containing Formoterol and Aclidiniumbromid (ATC R03AL05). All interested pharmaceutical companies can join under identical terms.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 05, 2027

Détails de la procédure

Date de publication
18 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
178186-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30